420 investor

North American cannabis stocks took a beating this week, with the North American Marijuana Index posting a 27.2 percent loss, largely on the back of poor performance among Canadian stocks. "The Canadian market collapsed this week after over $1.2 billion of deal offerings from publicly-traded...

Medical journal The Lancet published an article Wednesday that could mold the future of cannabis-derived therapeutics. The piece in question featured results from GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Greenwich Biosciences’ Phase 3 study of Epidiolex — an oral cannabidiol...

Despite early fears, it turned out 2017 was a pretty hot year for marijuana stocks. “This is a year where the patient were rewarded, which is not that surprising to me,” Alan Brochstein, founder of 420 Investor, said Dec. 28 on Benzinga's PreMarket Prep. Alarms were raised as...

Since the start of the year, the Canadian marijuana market has quietly exploded. The industry expanded from fewer than 10 publicly traded licensed producers to 23, all contributing to a total of 67. “It’s gotten a lot more challenging for people to kind of stumble into the Canadian...

Benzinga recently analyzed if MassRoots Inc (OTC: MSRT)'s acquisition of CannaRegs, Inc. for $12 million made sense. On one side of the spectrum was Alan Brochstein, author of the 420 Investor, who argued that the price tag was too high and that this could be seen as a proxy of MassRoots...

Despite being one of the most notable companies in the cannabis industry, MassRoots Inc (OTC: MSRT) has not always been great at creating value for shareholders. As Alan Brochstein, author of the 420 Investor, told Benzinga late last year, the company “endured a perfect storm of sorts ......

Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) lost more than 58 percent of their value Monday morning after the company reported disappointing results from its phase 2 STAR 1 clinical trial for its adult epilepsy treatment. Zynerba is one of the largest cannabinoid-focused pharmaceutical...

Back in April, Benzinga shared an interview with Joel Milton, CEO of Baker Technologies, one of the largest VC-backed cannabis companies in the U.S. The firm offers a customer engagement platform designed for marijuana dispensaries and brands, often dubbed “the salesforce.com, inc. (NYSE...

There’s an increasing tendency among publicly traded cannabis companies: making acquisitions using only or mostly stock, rather than cash. In fact, Benzinga recently shared a look into iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF)’s $17.3 million purchase of Valley Agriceuticals...

Nevada started selling cannabis for adult use just a couple of weeks ago and dispensaries are already running low on (or even out of) product. Almost every major media outlet in the U.S. has reported on this event, explaining the shortage is caused by distribution problems and inefficiencies rather...

MedReleaf Corp (TSE:LEAF), one of the major licensed cannabis producers in Canada, started trading on the TSX on Wednesday and its debut was far from pleasant. After opening at C$9.50 ($7.04), shares lost 22 percent, closing at C$7.40 ($5.48). According to Bloomberg data, this drop marked "the...

Alan Brochstein, also known as the 420 Investor, joined Benzinga's PreMarket Prep to discuss some of the top marijuana stocks. The Popular Play When it comes to one of the most popular marijuana plays on the market, GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH), Brochstein says the stock will...

What is success made of? While Benzinga strives to always ask the most pertinent and provoking questions during staff-conducted interviews, the team also attempts to gather intel on how investors think, what makes them tick and why they've had success. A big part of the job as a reporter is...

What is success made of? While Benzinga strives to always ask the most pertinent and provoking questions during staff-conducted interviews, the team also attempts to gather intel on how investors think, what makes them tick and why they've had success. A big part of the job as a reporter is...

Major cannabis stock indices have been falling for three consecutive weeks, ever since White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized, despite the Cole Memo. Some have referred to this slope as...